Improve Outcomes with Diverse Datasets

Scalable and secure data collection, annotation, and chatbot translation services.

Get AI Now
Translations Memory Life Sci

Deploy high-performance AI products to improve patients’ quality of life

Life sciences organizations continue to amass enormous amounts of unstructured data sets. The complexity of these vast collections of data can prevent sponsors and other clinical companies from accessing operational and patient efficiencies offered by machine learning.

TransPerfect Life Sciences' AI/ML data services resolve the complexity and enable machine learning models by converting unstructured data to structured data, combining highly efficient human input with state-of-the-art tools and workflows so that the result is accurate and unbiased.

HIPAA-Compliant Data Collection and Annotation Built for Scale

Ensure better-balanced datasets across 200+ languages with our data collection and annotation services, without breaking the bank. Our labeling team is comprised of ground truth experts, meaning all data provided comes by direct observation/measurement. From audio to video and images to text, our platform provides a scalable content moderation solution in secure facilities on the cloud.

Chatbot Localization

An estimated 80% of standard queries can be answered by chatbots. Our end-to-end chatbot localization service ensures your stakeholders receive accurate, fast responses in their native language through collecting global patient prompts; categorizing said prompts into groups; and then running user tests for compliance, conceptual equivalence, and cultural appropriateness.

Learn More ›

The Latest Developments in Artificial Intelligence for Life Sciences

Benefits of our AI Platform, DataForce

  • Stronger, global, diverse datasets
  • Recruiting large volumes of resources at scale
  • Up to 80% reduction in timelines
  • Flexible integration capabilities with our platform or third party of your choice
  • Up to 1,000 annotators onboarded within weeks of project kick-off
  • Compliant with SSAE 16 SOC 2, ISO 27001, HIPAA, & GDPR

Enhance Internal Efficiencies While Improving Patients' Quality of Life

For data scientists, machine learning engineers, and product managers looking to deploy high-performance AI products in the healthcare industry, DataForce by TransPerfect is a market leader in scalable and secure data collection and annotation services. DataForce converts unstructured data to structured data, combining highly efficient human input with state-of-the-art tools and workflows so that the result is accurate and unbiased to ensure companies are at the front line of innovation in bringing treatments and solutions to the world.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Achieve Better Data and Smarter AI Today.

Schedule a Free Consult.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our subject-matter experts have in-depth understanding of the technological challenges, requirements, and goals for life sciences organizations.

Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

When the EU Clinical Trial Regulation (EU CTR No 536/2014) went live for new submissions on January 31, 2022, it promised to transform how clinical trials are authorized and conducted across Europe: a single submission, one decision, and harmonized oversight. Four years in, the reality is more nuanced. The regulatory landscape, meanwhile, is moving faster than ever. In a recent Xtalks webinar, four subject matter experts with direct experience navigating CTR and ...

Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays

Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across ...

The Missing Link: Why Study Design Makes or Breaks a Clinical Trial

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study design is so often the overlooked "missing link" in clinical ...

C3 Summit 2026 - London

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...

Considerations for eCOA in Global Clinical Trials

Regulatory Considerations for eCOA Submissions in Global Clinical Trials: What You Need to KnowWhen managing eCOA in clinical trials across multiple countries, translation, linguistic validation, and electronic implementation of Clinical Outcome Assessments (COAs) are...

Xtalks | EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities

The EU clinical trial landscape has changed significantly since Regulation (EU) No 536/2014 became applicable on January 31, 2022, and sponsors now need a clear view of how the framework is operating in practice and where it may evolve next. This webinar explores the current ...

Veeva RIM TMS Integration Checklist

If your regulatory team is still downloading documents from Veeva Vault, managing translation requests by email, or tracking submissions in spreadsheets, there's a better way. Reduce complexity, close compliance gaps, and shorten your submission cycle times with this ...